Blonay, France

Claire Bouix-peter

This inventor holds 2 USPTO granted patents. Top assignee: Galderma Holding Sa. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claire Bouix-peter. Retrieved from https://idiyas.com/inventor/claire-bouix-peter-cmkmgjul

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Claire Bouix-Peter: Innovator in JAK Inhibitor Compounds

Introduction

Claire Bouix-Peter is a notable inventor based in Blonay, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitor compounds. Her work focuses on novel compounds that have the potential to treat various diseases, conditions, and disorders.

Latest Patents

Claire holds 1 patent for her innovative work titled "JAK inhibitor compounds, methods for synthesizing same and use thereof." This patent describes novel compounds with a specific formula and outlines methods for using these compounds in therapeutic applications.

Career Highlights

Claire is currently employed at Galderma Holding SA, a company known for its expertise in dermatological products. Her role involves research and development, where she applies her knowledge to create effective treatments.

Collaborations

Throughout her career, Claire has collaborated with esteemed colleagues such as Gilles Ouvry and Branislav Musicki. These partnerships have enhanced her research and contributed to the advancement of her projects.

Conclusion

Claire Bouix-Peter is a pioneering inventor whose work in JAK inhibitor compounds showcases her commitment to advancing medical science. Her contributions are poised to make a significant impact in the treatment of various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…